Partner | Lawyer | Certified Specialist Lawyer for Commercial and Corporate Law
Dr. Bernhard Noreisch LL.M.
Profile details
Dr Bernhard Noreisch specialises in M&A, venture capital, commercial and corporate law. His clients are mainly medium-sized companies, national and international investors, family offices and young companies, which he regularly assists in M&A transactions and financing rounds.
Besides, Dr Bernhard Noreisch is characterised by his high level of personal commitment, his negotiating skills, his experience, and his solution-oriented advice. Even in highly complex projects, he convinces with competence and his sympathetic and calm manner.
- Venture capital / private equity
- Acquisition and sale of companies / M&A
- Corporate law
- Commercial and contract law
- JUVE Handbook continuously since 2016 | 2017: Leading advisor for venture capital
- JUVE Handbook continuously since 2013 | 2014: Often recommended lawyer
- Handelsblatt & Best Lawyers: One of the best lawyers for corporate law (2021-2024), venture capital (2021-2024) and private equity (2020 – 2024)
- Legal 500 Germany (& EMEA) 2016 – 2024 continuously: Recommended lawyer
- Certified specialist lawyer for commercial and corporate law since 2007
- Lawyer at LUTZ | ABEL since 2003
- Admission to the bar, 2003
- Master's degree at the University of Edinburgh
- Doctorate (Dr. jur.) and additional training in economics in Bayreuth
- Law studies in Passau and Bayreuth
- Neura Robotics on EUR 50 m financing round
- Bayern Kapital GmbH with its ScaleUp Fonds Bayern on EUR 155 m financing round of Isar Aerospace
- Majority shareholder of Locoia on sale of locoia GmbH to Aareon Group
- APK AG in EUR 130 m financing round
- MIG-Fonds on EUR 128 m series A2 financing round of IQM Finland OY
- Samsung Catalyst Fund on USD 90 m series B financing round in Ada Health GmbH, 2021
- MIG-Fonds on USD 20 m series A investment in German Bionic Systems, 2020
- AMSilk on EUR 29 m series C financing round, 2021
- Dosimetrics on trade sale to Mirion Technologies, 2020
- Wachstumsfonds Bayern 2 and Bayern Kapital Innovationsfonds II on EUR 50 m financing round in CatalYm, 2020
- MIG-Fonds on EUR 39 m financing round in IQM, 2020
- SHS on investment in Blazejewski MEDI-TECH, 2019